GFOD1-AS1

Across TCGA pan-cancer cohorts, GFOD1-AS1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated GFOD1-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher GFOD1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GFOD1-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LUSC show a favorable association.

ACC, KIRC, and KIRP are the cancer types where GFOD1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.268	0.683	.008	57	view →
KIRC	DFS	Quartile	II,III,IV	0.760	0.359	.001	50	view →
KIRP	DFS	Quartile	IV	0.100	0.586	<.001	33	view →
BRCA	DFS	Quartile	All	0.933	0.957	.018	22	view →
LUSC	DFS	Quartile	II,III,IV	0.741	0.547	.007	19	view →
MESO	OS	Quartile	IV	0.889	0.240	.006	16	view →
LGG	OS	Quartile	All	0.942	0.853	.002	15	view →
COAD	OS	Median	IV	0.784	0.497	.031	14	view →
ESCA	OS	Tertile	All	1.000	0.602	.030	12	view →
THYM	DFS	Median	III,IV	1.000	0.402	.004	12	view →
DLBC	DFS	Quartile	All	0.620	0.939	.022	9	view →
CESC	OS	Tertile	II,III,IV	0.872	0.694	.019	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

GFOD1-AS1–ACC (OS)

Open the ACC breakdown →